Gadolinium-containing contrast media for radiographic examinations: A position paper

European Radiology

Volumn 12, Issue 10, 2002, Pages 2600-2605

  Thomsen, Henrik S ^a   Almèn, Torsten ^b   Morcos, Sameh K ^c   Aspelin, P ^b   Bellin, M F ^b   Clauss, W ^b   Flaten, H ^b   Grenier, N ^b   Idee J M ^b   Jakobsen, J A ^b   Krestin, G P ^b   Stacul, F ^b   Webb, J A W ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Sheffield Teaching Hosp NHS Trust ^*

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Contrast media; Gadolinium CM; Iodinated CM; Nephrotoxicity

Indexed keywords

CONTRAST MEDIUM; GADOBUTROL; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIC ACID; GADOTERIDOL; IODINATED CONTRAST MEDIUM; IOHEXOL; METRIZOIC ACID; RADIOACTIVE IODINE; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; BODY WEIGHT; CONCENTRATION (PARAMETERS); DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG SAFETY; HUMAN; ITALY; KIDNEY DISEASE; MEDICAL LITERATURE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIODIAGNOSIS; REVIEW; SYMPOSIUM; X RAY; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; LD 50; RABBIT; RADIOGRAPHY; SWINE;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; GADOLINIUM DTPA; HUMANS; KIDNEY DISEASES; LETHAL DOSE 50; RABBITS; RADIOGRAPHY; SWINE;

EID: 0036781912     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-002-1628-3     Document Type: Review

References (30)

1. Albrecht T, Dawson P (2000) Gadolinium-DTPA as X-ray contrast medium in clinical studies. Br J Radiol 73:878-882
2. Bittner CA, Goodwin SC, Lu D, McNamara TO, Joseph T (1997) Gadolinium-based contrast agents for angiographic use as a safe radiocontrast in patients with impaired renal function. J Vasc Interv Radiol (Suppl) 8:178
3. Engelbrecht V, Koch JA, Rassek M, Mödder U (1996) Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 165:24-28
4. Joffe P, Thomsen HS, Meusel M (1998) The pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency treated conservatively or undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5:491-502
5. Normann PT, Joffe P, Martinsen I, Thomsen HS (2000) Identification and quantification of gadodiamide in serum, peritoneal dialysate and faeces from end-stage renal patients dosed with gadodiamide injection by inductively coupled plasma-atomic emission spectroscopy and comparative analysis by high-performance liquid chromatography. J Pharm Biomed Anal 22:939-947
6. Weinmann JH, Press WR, Gries H (1990) Tolerance of extracellular contrast agents for magnetic resonance imaging. Invest Radiol 25:S49-S50
7. Weinmann HJ (1999) Gadolinium chelates: physico-chemical properties, formulation and toxicology. In: Dawson P, Cosgrove DO, Grainger RG (eds) Textbook of contrast media. Isis, Oxford, p 228
8. Niendorf HP, Gifford LM, Haustein J, Cornelius I, Alhassan A, Clauss W (1991) Tolerance data of Gd-DTPA: a review. Eur J Radiol 13:15-20
9. Thomsen HS (1997) Frequency of acute adverse events to a non-ionic low-osmolar contrast medium: the effect of verbal interview. Pharmacol Toxicol 80:108-110
10. Nyman U, Elmståhl B, Leander P, Nilsson M, Golman K, Almén T (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223:311-318
11. Prince MR, Arnoldus C, Frisoli JK (1996) Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1:162-166
12. Velmas T, Markkola T (1998) Gd-DTPA as an alternative contrast agent in conventional and interventional radiology. Acta Radiol 39:223-226
13. Coche EE, Hammer, FD, Gofette PP (2001) Demonstration of pulmonary embolism with dynamic gadolinium-enhanced spiral CT. Eur Radiol 11:2306-2309
14. Kaufmann JA, Geller SC, Bazari H, Waltman AC (1999) Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency: early experiences. Radiology 212:280-284
15. Matchett WJ, McFarland DR, Rusell DK, Sailors DM, Moursi MM (1996) Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography. Radiology 201:569-571
16. Gemery J, Idelson B, Reid S, Yucel EK, Pagin-Marin H, Alie S, Casserly L (1998) Acute renal failure after arteriography with a gadolinium-based contrast agent. Am J Roentgenol 171:1277-1278
17. Hammer FD, Gofette PP, Maliase J, Mathurin P (1999) Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography. Eur Radiol 9:128-136
18. Spinosa DJ, Matsumo AH, Angle JF, Hagspiel KD, Iassacs R (1998) Gadolinium-based contrast and carbon dioxide angiography to evaluate transplants for vascular causes of renal insufficiency and accelerated hypertension J Vasc Interv Radiol 9:909-916
19. Spinosa DJ, Matsumoto AH, Hagspiel KD, Angle JF, Hartwell GD (1999) Gadolinium-based contrast agents in angiography and interventional radiology. Am J Roentgenol 173:1403-1409
20. Spinosa DJ, Angle JF, Hagspiel, Kern JA, Hartwell GD, Matsumoto AH (2000) Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO2 angiography in patients with renal insufficiency. J Vasc Interv Radiol 11:35-43
21. Gemmete JJ, Forauer AR, Kazanjian S, Dasika N, Williams DM, Cho K (2001) Safety of large volume gadolinium angiography. J Vasc Interv Radiol 12:S28
22. Schenker MP, Solomon JA, Roberts DA (2000) Gadolinium arteriography complicated by acute pancreatitis and acute renal failure. J Vasc Interv Radiol 12:393
23. Terzi C, Sokmen S (1999) Acute pancreatitis induced by magnetic-resonance-imaging contrast agent. Lancet 354:1789-1790
24. Leander P, Allard P, Caillé JM, Golman K (1992) Early effect of gadopentetate and iodinated contrast media on rabbit kidneys. Invest Radiol 27:922-926
25. Thomsen HS, Dorph S, Larsen S, Horn T, Hemmingsen L, Skaarup P, Golman K, Svendsen O (1994) Urine profiles and kidney histology after intravenous injection of ionic and nonionic radiologic and magnetic resonance contrast media in normal rats. Acad Radiol 1:128-135
26. Thomsen HS, Dorph S, Larsen S, Horn T, Hemmingsen L, Skaarup P, Golman K, Svendsen O (1995) Urine profiles and kidney histology after intravenous injection of ionic and nonionic radiologic and magnetic resonance contrast media in rats with cisplatin nephropathy. Acid Radiol 2:675-682
27. Deray G, Dubois M, Martinez F, Baumelou B, Beaufils H, Bourboze R, Baumelou A, Jacobs C (1990) Renal effects radiocontrast agent in rats: a new model of acute renal failure. Am J Nephrol 10:507-513
28. Brillet G, Dubois M, Beaufils H, Bourboze R, Deray G (1994) Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats. Invest Radiol 29:352-354
29. Elmståhl B, Leander P, Nyman U, Chai C-M, Almén T, Frennby B (2002) Nephrotoxicity after renal angiography using iodine and gadolinium contrast media in pigs with renal damage. Acad Radiol 9 [Suppl 2]:S531-S534
30. Brown PWG, Haylor JL, Morcos SK, El Nahas AM (1993) The functional effects of gadolinium-DTPA on the isolated perfused rat kidney. Eur J Radiol 16:85-89